Nukkleus Inc (NUKK) - Net Assets
Based on the latest financial reports, Nukkleus Inc (NUKK) has net assets worth $-30.42 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.29 Million) and total liabilities ($43.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nukkleus Inc (NUKK) tangible net worth to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-30.42 Million |
| % of Total Assets | -228.91% |
| Annual Growth Rate | N/A |
| 5-Year Change | -353.03% |
| 10-Year Change | N/A |
| Growth Volatility | 69.14 |
Nukkleus Inc - Net Assets Trend (2013–2025)
This chart illustrates how Nukkleus Inc's net assets have evolved over time, based on quarterly financial data. See Nukkleus Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Nukkleus Inc (2013–2025)
The table below shows the annual net assets of Nukkleus Inc from 2013 to 2025. For live valuation and market cap data, see NUKK stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $-30.42 Million | -328.54% |
| 2024-09-30 | $-7.10 Million | -165.18% |
| 2023-09-30 | $10.89 Million | 0.00% |
| 2022-09-30 | $10.89 Million | -9.41% |
| 2021-09-30 | $12.02 Million | +962.23% |
| 2020-09-30 | $-1.39 Million | -7.77% |
| 2019-09-30 | $-1.29 Million | -129.56% |
| 2018-09-30 | $-563.53K | -60.39% |
| 2017-09-30 | $-351.35K | -48.64% |
| 2016-09-30 | $-236.38K | -968.03% |
| 2015-09-30 | $-22.13K | -1235.67% |
| 2014-09-30 | $-1.66K | -108.65% |
| 2013-09-30 | $19.15K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nukkleus Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11144161000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.11K | % |
| Other Comprehensive Income | $-2.28K | % |
| Other Components | $81.05 Million | % |
| Total Equity | $-30.42 Million | 100.00% |
Nukkleus Inc Competitors by Market Cap
The table below lists competitors of Nukkleus Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FASING SA
WAR:FSG
|
$12.66 Million |
|
Sahathai Terminal Public Company Limited
BK:PORT
|
$12.68 Million |
|
NSN Co. Ltd
KQ:031860
|
$12.68 Million |
|
Harta Djaya Karya Tbk Pt
JK:MEJA
|
$12.68 Million |
|
Femasys Inc
NASDAQ:FEMY
|
$12.65 Million |
|
Cosmos Health Inc.
NASDAQ:COSM
|
$12.65 Million |
|
Barramundi Group Ltd
OL:BARRA
|
$12.64 Million |
|
Sejoong Co. Ltd
KQ:039310
|
$12.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nukkleus Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -7,098,000 to -30,417,971, a change of -23,319,971.
- Net loss of 71,176,903 reduced equity.
- New share issuances of 172,854,000 increased equity.
- Other comprehensive income increased equity by 142,723.
- Other factors decreased equity by 125,139,791.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-71.18 Million | -234.0% |
| Share Issuances | $172.85 Million | +568.26% |
| Other Comprehensive Income | $142.72K | +0.47% |
| Other Changes | $-125.14 Million | -411.4% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Nukkleus Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-09-30 | $0.00 | $0.50 | x |
| 2014-09-30 | $0.00 | $0.50 | x |
| 2015-09-30 | $0.00 | $0.50 | x |
| 2016-09-30 | $0.00 | $0.50 | x |
| 2017-09-30 | $0.00 | $0.50 | x |
| 2018-09-30 | $-0.09 | $0.50 | x |
| 2019-09-30 | $-0.01 | $0.50 | x |
| 2020-09-30 | $-0.01 | $0.50 | x |
| 2021-09-30 | $0.05 | $0.50 | x |
| 2022-09-30 | $0.03 | $0.50 | x |
| 2023-09-30 | $0.03 | $0.50 | x |
| 2024-09-30 | $-4.11 | $0.50 | x |
| 2025-09-30 | $-3.74 | $0.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nukkleus Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-25.37%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -104.42% | -166.67% | 0.53x | 1.18x | $-21.92K |
| 2014 | 0.00% | -48.82% | 7.98x | 0.00x | $-50.09K |
| 2015 | 0.00% | -139.14% | 0.00x | 0.00x | $-42.96K |
| 2016 | 0.00% | -2.68% | 8.24x | 0.00x | $-236.63K |
| 2017 | 0.00% | -0.57% | 21.72x | 0.00x | $-101.72K |
| 2018 | 0.00% | -1.11% | 62.79x | 0.00x | $-155.83K |
| 2019 | 0.00% | -3.80% | 94.58x | 0.00x | $-600.64K |
| 2020 | 0.00% | -0.56% | 5.05x | 0.00x | $32.82K |
| 2021 | -7.79% | -4.86% | 1.16x | 1.39x | $-2.14 Million |
| 2022 | -108.77% | -55.06% | 1.17x | 1.69x | $-12.93 Million |
| 2023 | -108.77% | -55.06% | 1.17x | 1.69x | $-12.93 Million |
| 2024 | 0.00% | -144.07% | 6.00x | 0.00x | $-7.81 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-68.14 Million |
Industry Comparison
This section compares Nukkleus Inc's net assets metrics with peer companies in the Aerospace & Defense industry.
Industry Context
- Industry: Aerospace & Defense
- Average net assets among peers: $1,119,318,888
- Average return on equity (ROE) among peers: -2.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nukkleus Inc (NUKK) | $-30.42 Million | -104.42% | N/A | $12.65 Million |
| Archer Aviation Inc (ACHR) | $493.30 Million | -64.32% | 0.16x | $4.09 Billion |
| AAR Corp (AIR) | $1.21 Billion | 1.03% | 1.35x | $4.68 Billion |
| Air Industries Group (AIRI) | $-774.42K | 0.00% | 0.00x | $14.65 Million |
| AIRO Group Holdings, Inc. Common Stock (AIRO) | $623.00 Million | -4.10% | 0.18x | $206.21 Million |
| Arxis, Inc. Class A Common Stock (ARXS) | $2.98 Billion | -1.86% | 1.12x | $2.82 Billion |
| Astronics Corporation (ATRO) | $60.11 Million | -6.32% | 1.31x | $2.42 Billion |
| AeroVironment Inc (AVAV) | $382.19 Million | 3.43% | 0.13x | $8.46 Billion |
| AEVEX Corp. (AVEX) | $590.07 Million | -0.14% | 0.37x | $1.01 Billion |
| Axon Enterprise Inc. (AXON) | $117.56 Million | -3.73% | 0.16x | $34.10 Billion |
| The Boeing Company (BA) | $4.74 Billion | 46.74% | 9.93x | $174.71 Billion |
About Nukkleus Inc
Nukkleus Inc., through its subsidiaries, engages primarily in the supply of generators for iron dome launchers and other defense products. It is also involved in the engineering, design, production, integration, sale, and maintenance of special tactical vehicles and trailers, including reconnaissance vehicles, mobile command and control vehicles, firefighting trailers, energy and lighting trailer… Read more